Athanor Capital’s West Pharmaceutical WST Stock Holding History

Athanor Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,250	Closed	-$344K	–	831
2020 Q3	$344K	Buy	+1,250	New	+$331K	0.01%	397

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Athanor Capital's WST Position: Q4 2020 in Review

Athanor Capital sold out of West Pharmaceutical (WST) in Q4 2020, closing a stake of 1,250 shares — an estimated $344K sold.

Athanor Capital first reported a position in WST in Q3 2020 and held it in 1 quarter. The position peaked at $344K in Q3 2020. 592 funds tracked by Wall St. Rank hold WST as of Q4 2020.

Athanor Capital reported no remaining West Pharmaceutical position as of Q4 2020 after selling out during the quarter.
Athanor Capital sold 1,250 West Pharmaceutical shares in Q4 2020, an estimated $344K.
Athanor Capital first reported a position in West Pharmaceutical in Q3 2020 and held it in 1 quarter.
Athanor Capital's West Pharmaceutical position peaked at $344K in Q3 2020.
592 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2020.

Based on Athanor Capital's 13F filing for Q4 2020, filed 16 Feb 2021.